echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > CPhI & P-MEC China 2021 invites you to build a pharmaceutical innovation ecosystem

    CPhI & P-MEC China 2021 invites you to build a pharmaceutical innovation ecosystem

    • Last Update: 2021-10-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Hosted by Informa Markets and China Chamber of Commerce for Import and Export of Medicines and Health Products, and co-organized by Shanghai Bohua International Exhibition Co.
    , Ltd.
    , "The 21st World Pharmaceutical Raw Materials China Exhibition" and "The 16th World Pharmaceutical Machinery, Packaging Equipment and Materials China Exhibition" "(CPhI & P-MEC China 2021) will start a new journey at the Shanghai New International Expo Center on December 16-18
    .
    With an exhibition scale of 200,000 square meters, the exhibition will play the strongest voice in the era of China's pharmaceutical industry with nearly 3,000 domestic and foreign exhibitors and more than 70,000 professional audiences online and offline
    .
    Responding to changes and multi-dimensional challenges to temper the international competitiveness of China's pharmaceuticals.
    Reviewing the "13th Five-Year Plan" period, a number of medical reform policies such as generic drug consistency evaluation, centralized procurement, and national talks have been continuously implemented.
    China's pharmaceutical industry is experiencing a marketing-driven trend.
    R&D is the first major change
    .
    Nowadays, as China moves from a "big pharmaceutical country" to a "powerful pharmaceutical country", pharmaceutical companies will usher in an unprecedented period of strategic opportunities in a win-win competition
    .
    Since entering China for the first time in 2001, CPhI China has always intensively cultivated and optimized services with an international perspective.
    While witnessing the rapid progress and growth of China's pharmaceutical industry, it has developed into a new situation to promote Chinese medicine The industry is an important carrier for efficiently embedding in the global value chain and realizing the new layout and development of internationalization
    .
    In the era of rapid digital development, CPhI & P-MEC China has long been at the forefront of Internet trade.
    Through the establishment of an official online B2B platform, customizable "cloud" + "exhibition" linkage, etc.
    , it comprehensively promotes domestic and foreign pharmaceutical companies to achieve trade Get on track
    .
    At the same time, there are more than a hundred exhibition conference activities, deep integration of current global industry hot trends, building a multi-dimensional three-dimensional communication platform, and strong empowerment for enterprises to achieve sustainable development
    .
    Promoting in depth, CPhI China has witnessed the new force of Chinese pharmaceutical companies as a large-scale, highly internationalized and influential professional event among similar themed exhibitions in Asia.
    For 21 years, CPhI China has witnessed China’s pharmaceutical industry’s “great progress” Significant change from "big export" to "excellent in and out"
    .
    Pioneer and founding exhibitors represented by Xinhua Pharmaceutical, Huahai Pharmaceutical, Jiuzhou Pharmaceutical, and Haixiang Pharmaceutical have grown up with CPhI China.
    They have drawn their own strategic blueprints and drawn the latitude and longitude lines of the industrial pattern during years of industrial synergy.
    , And gradually have the core competitiveness of the international market
    .
    On the stage of innovation and development of China's pharmaceutical industry, in addition to the larger and more mature companies that are well-known to the public, there are also a number of emerging forces that should not be underestimated
    .
    Under the favorable environment of scientific and regulatory compliance of pharmaceutical policies year by year, this part of small and medium-sized start-ups have also realized the brand from scratch during the several years of participating in CPhI China, and has begun to take shape in the industry market
    .
    With the growth of the company, the exhibition platform has also been vertically extended to pharmaceutical raw materials, intermediates and fine chemicals, pharmaceutical excipients, formulations, contract customization, biopharmaceuticals, natural extracts, veterinary drugs and feed, pharmaceutical machinery, packaging materials, laboratories The 15 sub-sectors of equipment, environmental protection and cleanliness, pharmaceutical logistics, automation and information technology, and epidemic prevention materials have established a two-way platform with deep participation of both supply and demand for pharmaceutical companies to optimize the layout of the industrial chain and accelerate transformation and innovation
    .
    At the same time, the international strategic layout of pharmaceutical companies is to take precautions, and this industrial synergy will surely help Chinese pharmaceutical companies ride the wind and waves on the route of high-quality development and move forward with their dreams
    .
    At the exhibition, we worked together to draw a new level of thinking about the pharmaceutical industry.
    CPhI China's contribution to the internationalization of China's pharmaceutical industry is not only reflected in the trade side, but also in promoting regulatory policies in line with international standards, R&D standards and quality compliance internationalization.
    Promote all-round, multi-level, and wide-ranging participation of Chinese pharmaceutical companies in international pharmaceutical innovation and research cooperation, and gradually increase the international influence of China's pharmaceutical industry
    .
    In the "post-epidemic" era, how to find an effective path for the high-quality international development of China's pharmaceutical industry in the global R&D and innovation, and to promote the stability and long-term development of China's pharmaceutical industry is of vital importance
    .
    In order to fully promote in-depth exchanges at all levels of global regulatory agencies, industry organizations, research institutes, and enterprises, the fifth "China Pharma Week" high-end conference activity week is coming again, covering leaders’ dialogue, business development, efficient social networking, Six main lines of selection, information sharing, and product innovation
    .
    More than a hundred heavy conference activities will fully radiate the hot spots of the pharmaceutical industry chain, and industry leaders will gather to share practical topics such as the international pharmaceutical market situation, new trends in drug regulatory policies and regulations, and technological innovation
    .
    At that time, the event week will provide high-level and in-depth social feasts for industry insiders before, during and after the exhibition, provide effective support for enterprises to optimize strategic deployment, explore international business opportunities, and jointly build a pharmaceutical R&D innovation ecosystem
    .
    The on-site meeting gathers strength to move forward and jointly launch the CPhI China 2021 flash "medicine" journey.
    As one of the grand events leading the global pharmaceutical development pattern, CPhI China integrates the entire industry chain in one place
    .
    Participating groups cover domestic and overseas pharmaceutical manufacturers, distributors/import and export companies, biopharmaceuticals and technology companies, pharmaceutical machinery, epidemic prevention materials, contract research and development and outsourcing, supervision/marketing, food and beverage/health food companies, laboratory construction and equipment , Environmental protection and engineering, packaging materials/drug system, pharmaceutical engineering, automation and other fields
    .
    The exhibition will spare no effort to assist people in all links of the pharmaceutical industry chain to explore innovative models of the pharmaceutical industry in a high-quality business cooperation and negotiation environment, release new energy in the industry, and discuss new developments in the industry
    .
    From December 16th to 18th, well-known domestic and overseas exhibitors and industry leading figures will gather at the Shanghai New International Expo Center
    .
    We sincerely invite you to come to the scene and start the “medicine” journey of CPhI China 2021
    .
    The audience pre-registration is in full swing, and the pre-registration will save 100 yuan on-site tickets immediately
    .
    Exhibition and media consultation: China Chamber of Commerce for Import and Export of Medicines and Health Products: Ms.
    Wu / Ms.
    Liu Tel: 010-58036296 / 6334 Shanghai Bohua International Exhibition Co.
    , Ltd.
    : Ms.
    Mao / Ms.
    Wang Tel: 021-33392250 / 2321
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.